PLG microsphere size controls drug release rate through several competing factors.
about
Future Prospects for Scaffolding Methods and Biomaterials in Skin Tissue Engineering: A ReviewDelivery of S1P receptor-targeted drugs via biodegradable polymer scaffolds enhances bone regeneration in a critical size cranial defect.Controlled protein release from monodisperse biodegradable double-wall microspheres of controllable shell thicknessPrecise control of PLG microsphere size provides enhanced control of drug release rate.Protein encapsulation in and release from monodisperse double-wall polymer microspheres.Osteochondral interface tissue engineering using macroscopic gradients of bioactive signals.Three-dimensional macroscopic scaffolds with a gradient in stiffness for functional regeneration of interfacial tissues.Chemistry with spatial control using particles and streams().Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time.Relationships between the phagocytic ability of milk macrophages and polymorphonuclear cells and somatic cell counts in uninfected cowsPreparation and in vitro characterization of dexamethasone-loaded poly(D,L-lactic acid) microspheres embedded in poly(ethylene glycol)-poly({varepsilon}-caprolactone)-poly(ethylene glycol) hydrogel for orthopedic tissue engineering.Long-acting injectable hormonal dosage forms for contraception.Controlled delivery of gentamicin using poly(3-hydroxybutyrate) microspheresMicrospheres for controlled release drug delivery.NanoCipro encapsulation in monodisperse large porous PLGA microparticles.Influence of particle size and antacid on release and stability of plasmid DNA from uniform PLGA microspheresMathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres--a reviewEncapsulation of protein nanoparticles into uniform-sized microspheres formed in a spinning oil film.Microsphere-based seamless scaffolds containing macroscopic gradients of encapsulated factors for tissue engineeringMicrosphere-based scaffolds for cartilage tissue engineering: using subcritical CO(2) as a sintering agent.Microparticles produced by the hydrogel template method for sustained drug deliveryRevolutionizing drug delivery through biodegradable multilayered particles.Preparation and evaluation of cefquinome-loaded gelatin microspheres and the pharmacokinetics in pigs.Polymer degradation and drug delivery in PLGA-based drug-polymer applications: A review of experiments and theories.The effect of AZD2171- or sTRAIL/Apo2L-loaded polylactic-co-glycolic acid microspheres on a subcutaneous glioblastoma model.Drug encapsulated aerosolized microspheres as a biodegradable, intelligent glioma therapy.Development and in vitro characterization of poly(lactide-co-glycolide) microspheres loaded with an antibacterial natural drug for the treatment of long-term bacterial infections.Functionalized PLGA-doped zirconium oxide ceramics for bone tissue regeneration.A short term quality control tool for biodegradable microspheres.Biodegradable Polymeric Microsphere-Based Drug Delivery for Inductive Browning of Fat.An Approach to the Design of a Particulate System for Oral Protein Delivery .II. Preparation and Stability Study of rhGH-Loaded Microspheres in Simulated Gastrointestinal Fluids.Subcritical CO2 sintering of microspheres of different polymeric materials to fabricate scaffolds for tissue engineering.Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies.Biodegradable rifampicin-releasing coating of surgical meshes for the prevention of bacterial infections.Controlled release of imatinib mesylate from PLGA microspheres inhibit craniopharyngioma mediated angiogenesis.Application of Carbopol/PVP interpolymer complex to prepare mucoadhesive floating granule.Injectable PLGA microsphere/calcium phosphate cements: physical properties and degradation characteristics.Reduction in the initial-burst release by surface crosslinking of PLGA microparticles containing hydrophilic or hydrophobic drugs.Liquid crystal elastomer foams with elastic properties specifically engineered as biodegradable brain tissue scaffolds.Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo.
P2860
Q28077861-4A5C661E-1EF1-4B09-900B-4DC4FCF2576FQ30406089-F4FC22D4-44D8-4E4A-BC1C-3964C34F72A9Q30422389-9CDD81C6-FDC7-463A-B99A-7FD6815F17CCQ30432709-5519888A-7A8E-4999-BBA1-7483CAA3AEE6Q30442084-E3960FFB-0C72-4105-89B3-A08ED0B081E5Q30449330-89913CC7-5779-4E03-8101-F48B13519194Q30474335-E7FB1E24-56E4-4708-A0E4-C2C8861E141DQ30528061-DDF7D185-E34C-4E14-A9BC-FA9A18820DBAQ34038784-C2074D54-DC13-49BC-A259-35300F6E89BAQ34248645-2963D26E-89DA-4B76-B258-A4F9A24A0C5FQ34259149-80AA9F7E-6B8D-48B1-B791-4C2974B90E55Q34472933-5AB87449-CC47-40E6-A1F3-132039116689Q35162107-27409901-7916-4D08-8A7D-E3B9034642E4Q35609775-64B48981-786D-4706-A852-8ED3B6835969Q36091853-5CCEB414-D290-444C-BC96-9C6AA1829658Q36276099-56119DF1-67EE-4107-89C1-38993BBAE40CQ36456955-036754A7-F2D6-4417-A781-5743AC26BE91Q37360922-820DC52D-96C7-467E-B112-C8F382EE9224Q37389303-D16499B1-8E51-4B99-94CF-F00EC8C079DBQ37455673-04FC7530-9E73-4BA8-846A-F956D6D7237DQ37576526-4B47B43F-6971-461B-8C4F-F1137E925139Q38022059-638A1DF3-B7B4-4E3C-B79E-1BF31D6E0C47Q38705636-F226E25C-D71A-4BE1-A23A-53D3135483E9Q38813199-AE7C71D8-DD28-42A3-8888-9EE2BB10D710Q38867453-EA7FF35C-1563-47F2-9543-D5EF25BA9FD6Q38978069-415E00F8-9B77-48E7-ACD5-E4E7F6D689BCQ39359449-957E90FD-3294-412B-8104-30D6CAD91203Q39376814-530060AC-4D22-48E1-84E0-04B7DBB36363Q40027648-BADB4B38-4785-42F1-AD92-8C931CCA37D7Q40263189-425564ED-855B-440E-ABA7-BD6C5DA27B23Q42040493-E97421EF-9768-43C7-8658-AC32EDE2DCF2Q42118089-A90CDEF5-9635-4228-880C-D5FC08C48C7BQ42374691-E4530586-87B1-4EE1-B6B9-1923028C9FBFQ42731693-0D22928A-8080-4E4A-9FB0-4A1949B7EAF2Q44556811-814DE4D4-6BF9-4E96-B7DE-BEA72E7055BFQ44891668-A0E84A0A-B0F5-4AAC-BB3C-03E37D95B7F1Q45103177-994650F1-F920-4661-9EF8-16BC4CBD06E8Q45260317-873F8C41-E477-4D6D-8F5F-0E88A63E30EEQ47253724-C6B0FA5D-A767-4A6A-AF59-AF592BE07C1BQ47331581-EC8D89DC-F715-455D-967E-E799561E1CB2
P2860
PLG microsphere size controls drug release rate through several competing factors.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
PLG microsphere size controls drug release rate through several competing factors.
@en
PLG microsphere size controls drug release rate through several competing factors.
@nl
type
label
PLG microsphere size controls drug release rate through several competing factors.
@en
PLG microsphere size controls drug release rate through several competing factors.
@nl
prefLabel
PLG microsphere size controls drug release rate through several competing factors.
@en
PLG microsphere size controls drug release rate through several competing factors.
@nl
P2093
P356
P1476
PLG microsphere size controls drug release rate through several competing factors.
@en
P2093
Cory Berkland
Daniel W Pack
Kyekyoon Kim
P304
P356
10.1023/A:1024466407849
P577
2003-07-01T00:00:00Z